MIT Cancer Research Center Selects JEOL Microscope

Electron optical equipment and instrumentation provider JEOL USA Inc. announced that the David H. Koch Institute for Integrative Research at MIT has selected its JEM-2100F transmission electron microscope (TEM) for its new microscopy core.

Suitable for biological and materials applications, the 200 kV field emission TEM offers a highly flexible platform and features rapid data acquisition with uncompromised resolution and analytical performance.

It will be configured with the Gatan GIF quantum post-column energy filter for capture of both detailed EELS and EFTEM data sets at high throughputs.

“JEOL is honored to partner with this cutting edge research center and to be a part of the intense efforts of the Cambridge/Boston biotech supercluster to develop new treatments to combat cancer,” said Richard Lois, director of sales at JEOL USA. “The JEM-2100F will be used for nanomaterials characterization in this unique research environment that connects the talents and resources of the number one school of engineering with those of leaders in the field of life sciences at MIT and surrounding hospitals.”

The Koch Institute brings the powers of both the School of Science and the School of Engineering at MIT in proximity to each other. The faculty from both schools will be utilized to create a highly collaborative environment where they will work together in very specific technical areas relevant to inventing new types of solutions that will improve the lives of cancer patients, said Robert Urban, executive director of the facility.

The institute is also partnering with Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals Inc. via the Transcend program to foster oncology research and technology development in the areas of cancer diagnostics, cancer biology pre-malignancies, genetic models of disease and profiles of the tumor microenvironment.

For more information, visit: www.jeolusa.com